Pharmacokinetic behavior of intraperitoneal teicoplanin during treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
Finch
R C
RC
Holliday
A P
AP
Innes
A
A
Burden
R P
RP
Morgan
A G
AG
Shaw
P N
PN
Harding
I
I
Wale
M C
MC
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001398:Aztreonam / Q000008:administration & dosage / Q000627:therapeutic use; D015314:Dialysis Solutions / Q000737:chemistry; D006801:Humans; D008997:Monobactams / Q000008:administration & dosage / Q000627:therapeutic use; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D017334:Teicoplanin / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D015314:Dialysis Solutions; D008997:Monobactams; D017334:Teicoplanin; D001398:Aztreonam